Form 4: Agios Pharmaceuticals Executive Theodore James Jr. Washburn Sells Shares
SEC Form 4 Filing
The Principal Accounting Officer of Agios Pharmaceuticals, Theodore James Jr. Washburn, sold 1,362 shares of common stock on June 3, 2024.
Summary
- On June 3, 2024, Theodore James Jr. Washburn, the Principal Accounting Officer of Agios Pharmaceuticals, sold 1,362 shares of the company's common stock.
- The shares were sold at a price of $44.39 per share.
- Following the transaction, Washburn directly owns 1,524 shares of Agios Pharmaceuticals.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a sale of shares by an insider. It doesn't inherently convey positive or negative sentiment, but the market may interpret insider selling as slightly negative.
Industry Context
Form 4 filings are a routine part of the financial markets, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Stakeholder Impact
- Shareholders may interpret the insider sale as a signal, although it could be for personal financial reasons and not necessarily indicative of the company's performance.
Key Dates
| Date | Description |
|---|---|
| 06/03/2024 | Date of the transaction: Theodore James Jr. Washburn sold 1,362 shares of Agios Pharmaceuticals common stock. |
| 06/05/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.